Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

Clinical trial NCT00868452 · COMPLETED

Trial details

NCT number: NCT00868452
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Depression

Start date: 2009-04-01
Primary completion: 2011-12-01
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.